Epidemiology and risk factors for ovarian cancer.
aetiology
epidemiology
family history
genetics
older age
ovarian cancer
Journal
Przeglad menopauzalny = Menopause review
ISSN: 1643-8876
Titre abrégé: Prz Menopauzalny
Pays: Poland
ID NLM: 101263235
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
09
12
2022
accepted:
01
03
2023
medline:
7
9
2023
pubmed:
7
9
2023
entrez:
7
9
2023
Statut:
ppublish
Résumé
Ovarian cancer is a complex disease, mostly observed in postmenopausal women, and is associated with poor survival rates. It is the sixth most common cancer and the fifth most common cause of death due to cancer among women in developed countries. Thus, despite representing less than one third of all gynaecologic cancers, deaths due to ovarian cancer account for more than two thirds of deaths due to gynaecologic cancers. Its prevalence is higher in Western Europe and Northern America than Asia and Africa. In sub-Saharan Africa, there is a considerably lower prevalence of ovarian cancer than other parts of Africa. Ovarian cancer is multifaceted, involving many factors, complex biological processes and unpredictable consequences. Unlike other female cancers that have early warning symptoms, ovarian cancer's symptoms are non-specific. As a result, ovarian cancers are normally undetected until advanced stages (III or IV). The major risk factors for ovarian cancer include older age, genetics, family history, hormone replacement therapy, nulliparity, and dietary fat. Controversial factors include obesity, infertility, talc powder, radiation exposure, fertility medications and in vitro fertilization. The current review discusses the aetiology, epidemiology and risk factors for ovarian cancer. Nevertheless, identification of the main risk factors for ovarian cancer may increase the awareness among women of the general population. This should help to decrease the incidence rate of ovarian cancer and increase the five-year survival rate.
Identifiants
pubmed: 37674925
doi: 10.5114/pm.2023.128661
pii: 50846
pmc: PMC10477765
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
93-104Informations de copyright
Copyright © 2023 Termedia.
Références
Sci Rep. 2021 Mar 8;11(1):5405
pubmed: 33686097
Cancer Prev Res (Phila). 2013 Aug;6(8):811-21
pubmed: 23761272
Hum Reprod Update. 2007 Sep-Oct;13(5):453-63
pubmed: 17573406
Fertil Steril. 2013 Dec;100(6):1660-6
pubmed: 24011610
N Engl J Med. 1994 Sep 22;331(12):771-6
pubmed: 8065405
Medicine (Baltimore). 2021 Jan 29;100(4):e23816
pubmed: 33530178
Lancet Oncol. 2012 Sep;13(9):946-56
pubmed: 22863523
N Engl J Med. 2009 Jul 9;361(2):170-7
pubmed: 19587342
Obstet Gynecol. 1997 Jun;89(6):1012-6
pubmed: 9170483
Am J Obstet Gynecol. 2021 Jul;225(1):51.e1-51.e17
pubmed: 33493488
Cell Rep. 2021 Jul 20;36(3):109412
pubmed: 34289354
Expert Opin Ther Targets. 2012 Jan;16(1):15-31
pubmed: 22239438
Fertil Steril. 2009 Apr;91(4):1152-8
pubmed: 18371964
Obstet Gynecol. 2004 Jun;103(6):1194-203
pubmed: 15172852
Am J Epidemiol. 1992 Nov 15;136(10):1184-203
pubmed: 1476141
Eur J Cancer. 2018 Jan;88:31-37
pubmed: 29179135
World J Clin Oncol. 2020 Nov 24;11(11):868-889
pubmed: 33312883
Cancer. 2006 Sep 1;107(5 Suppl):1162-71
pubmed: 16838312
Gynecol Oncol. 2006 Jan;100(1):83-8
pubmed: 16137751
Ceska Gynekol. 2020 Winter;85(1):49-58
pubmed: 32414285
Am J Epidemiol. 2016 May 1;183(9):800-14
pubmed: 27190045
Curr Oncol. 2015 Aug;22(4):e233-6
pubmed: 26300672
JAMA. 2020 Jan 7;323(1):49-59
pubmed: 31910280
Obstet Gynecol. 2016 May;127(5):828-836
pubmed: 27054934
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Womens Health (Lond). 2012 Sep;8(5):543-55
pubmed: 22934728
Gynecol Oncol. 2013 Feb;128(2):260-4
pubmed: 23116937
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1677-86
pubmed: 23880734
Gynecol Oncol. 2013 May;129(2):372-6
pubmed: 23385152
Int J Cancer. 2011 Dec 15;129(12):2885-93
pubmed: 21671469
Am J Obstet Gynecol. 1990 Feb;162(2):502-14
pubmed: 2178432
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
J Clin Oncol. 2014 May 20;32(15):1547-53
pubmed: 24567435
Cancer. 2021 Jun 15;127(12):2091-2098
pubmed: 33620751
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Cancer Metastasis Rev. 2010 Jun;29(2):339-50
pubmed: 20405170
J Natl Cancer Inst. 2014 Sep 10;106(9):
pubmed: 25214560
Nat Commun. 2020 Nov 27;11(1):6084
pubmed: 33247094
J Natl Cancer Inst. 2002 Apr 3;94(7):497-504
pubmed: 11929950
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Curr Cancer Drug Targets. 2018;18(6):567-576
pubmed: 28637409
Int J Obes (Lond). 2020 Jul;44(7):1546-1560
pubmed: 31974406
BMJ. 2009 Feb 05;338:b249
pubmed: 19196744
Bosn J Basic Med Sci. 2013 May;13(2):89-93
pubmed: 23725504
Cancers (Basel). 2022 Jan 14;14(2):
pubmed: 35053578
Int J Cancer. 2020 May 15;146(10):2756-2772
pubmed: 31443135
JAMA Oncol. 2020 Jun 1;6(6):e200421
pubmed: 32239218
Int J Cancer. 2020 Oct 15;147(8):2121-2130
pubmed: 32285933
Cancer Causes Control. 2013 May;24(5):989-1004
pubmed: 23456270
J Prev Med Public Health. 2016 May;49(3):143-52
pubmed: 27255073
Science. 2015 Dec 11;350(6266):1391-6
pubmed: 26541605
Carcinogenesis. 2000 Mar;21(3):427-33
pubmed: 10688862
Asian Pac J Cancer Prev. 2009 Apr-Jun;10(2):227-30
pubmed: 19537889
J Ovarian Res. 2021 May 4;14(1):63
pubmed: 33941230
Epidemiology. 2016 Nov;27(6):797-802
pubmed: 27327020
Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1411-1417
pubmed: 27197282
Br J Cancer. 2009 Jun 2;100(11):1824-31
pubmed: 19436296
Eur Radiol. 2020 Oct;30(10):5370-5373
pubmed: 32468105
Hum Reprod. 2011 Dec;26(12):3456-65
pubmed: 22031719
Gynecol Oncol. 2020 Mar;156(3):552-560
pubmed: 31902686
Jpn J Clin Oncol. 2015 Dec;45(12):1107-15
pubmed: 26491203
Br J Cancer. 2008 Jan 15;98(1):199-205
pubmed: 18071361
Int J Cancer. 2013 Nov 15;133(10):2415-21
pubmed: 23650079
Br J Cancer. 2015 Mar 31;112(7):1257-65
pubmed: 25742479
Clin Cancer Res. 2016 Dec 1;22(23):5909-5914
pubmed: 27521449
Lancet. 1995 Oct 14;346(8981):995-1000
pubmed: 7475593
J Ovarian Res. 2021 Nov 11;14(1):153
pubmed: 34758846
Cancer. 2009 May 15;115(10):2222-33
pubmed: 19241424
Fertil Steril. 2016 Mar;105(3):781-785
pubmed: 26698676
Br J Cancer. 1999 Oct;81(3):559-63
pubmed: 10507786
Eur J Cancer Prev. 2017 Jan;26(1):55-62
pubmed: 26731563
Cochrane Database Syst Rev. 2013 Aug 13;(8):CD008215
pubmed: 23943232
Nat Commun. 2021 Feb 12;12(1):970
pubmed: 33579919
J Clin Oncol. 2016 Aug 20;34(24):2888-98
pubmed: 27325851
JAMA Netw Open. 2021 Mar 1;4(3):e213520
pubmed: 33779745
Int J Cancer. 2018 Jan 15;142(2):281-289
pubmed: 28929490
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22
pubmed: 23628597
Cancers (Basel). 2022 Jul 02;14(13):
pubmed: 35805026
Am J Epidemiol. 1998 Jun 1;147(11):1038-42
pubmed: 9620047
Clin Genet. 2013 Nov;84(5):407-14
pubmed: 24025038
Epidemiology. 2016 May;27(3):334-46
pubmed: 26689397
Ann Surg Oncol. 2013 May;20(5):1514-21
pubmed: 23224829
Int J Cancer. 1999 Apr 12;81(2):214-8
pubmed: 10188721
Gynecol Oncol. 2022 Mar;164(3):514-521
pubmed: 35063280
J Surg Oncol. 2008 Feb 1;97(2):103-7
pubmed: 17979133
Gynecol Endocrinol. 2012 Oct;28(10):809-14
pubmed: 22475084
Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1839-1848
pubmed: 35900194
J Clin Oncol. 2013 Feb 20;31(6):738-43
pubmed: 23284037
Acta Obstet Gynecol Scand. 2015 Jan;94(1):86-94
pubmed: 25256594
JAMA. 2000 May 3;283(17):2260-5
pubmed: 10807385
Cancer Causes Control. 2001 Nov;12(9):855-63
pubmed: 11714114
Steroids. 2003 Nov;68(10-13):1033-9
pubmed: 14667996
Am J Obstet Gynecol. 2014 May;210(5):471.e1-11
pubmed: 24412119
Am J Med. 2008 Jun;121(6):501-508.e3
pubmed: 18501231
Hum Reprod Update. 2014 Sep-Oct;20(5):748-58
pubmed: 24688118
Radiology. 2020 May;295(2):439-445
pubmed: 32154776
J Natl Cancer Inst. 2003 Aug 20;95(16):1244-8
pubmed: 12928351
Nutr Cancer. 2019;71(6):939-953
pubmed: 31058552
HIV Med. 2016 Oct;17(9):702-7
pubmed: 26991340
Lancet Oncol. 2007 Jan;8(1):26-34
pubmed: 17196508
Curr Opin Genet Dev. 2010 Jun;20(3):231-8
pubmed: 20456938
Genet Med. 2020 Oct;22(10):1653-1666
pubmed: 32665703
Fertil Steril. 2014 Jul;102(1):192-198.e3
pubmed: 24825424
Br J Cancer. 1996 Jul;74(2):280-4
pubmed: 8688336
J Clin Oncol. 2008 Mar 10;26(8):1239-46
pubmed: 18323547
Ann Oncol. 2013 Nov;24 Suppl 8:viii83-viii95
pubmed: 24131978
PLoS Genet. 2013;9(3):e1003212
pubmed: 23544013
PLoS One. 2015 Jul 09;10(7):e0131190
pubmed: 26158818
Gynecol Oncol. 2006 Dec;103(3):1122-9
pubmed: 17005245
Cancer Res. 2006 Aug 15;66(16):8297-308
pubmed: 16912212
Health Technol Assess. 1998;2(2):i-iv, 1-84
pubmed: 9561894
Curr Cancer Drug Targets. 2018;18(6):522-537
pubmed: 29295697
Ann Epidemiol. 2016 Sep;26(9):654-62
pubmed: 27528178